Table 2. Baseline characteristics of dogs according to their treatment group.
| G0 (n = 45) | G1 (n = 16) | G2 (n = 31) | Total (n = 92) | p-value | |
|---|---|---|---|---|---|
| Sex, n (%) | 0.070 | ||||
| Female | 12 (27) | 4 (25) | 16 (52) | 32 (35) | |
| Spayed female | 10 (22) | 5 (31) | 3 (10) | 18 (19) | |
| Male | 14 (31) | 6 (38) | 11 (35) | 31 (34) | |
| Castrated male | 9 (20) | 1 (6) | 1 (3) | 11 (12) | |
| Age (years), median (range) | 6.18 (1–16) | 4.09 (2.0–10) | 4.18 (1.0–11) | 6.00 (1–16) | 0.023 |
| Follow-up time (months), median (range) | 16.2 (3–84) | 13.0 (3–30) | 13.5 (3–49) | 14.9 (3–84) |
G0: dogs without treatment, control group; G1: dogs receiving topical 1% CsA once daily; G2: dogs receiving topical 1%CsA twice daily.